![Cystathionine β‐synthase deficiency in the E‐HOD registry‐part I: pyridoxine responsiveness as a determinant of biochemical and clinical phenotype at diagnosis - Kožich - 2021 - Journal of Inherited Metabolic Disease - Wiley Cystathionine β‐synthase deficiency in the E‐HOD registry‐part I: pyridoxine responsiveness as a determinant of biochemical and clinical phenotype at diagnosis - Kožich - 2021 - Journal of Inherited Metabolic Disease - Wiley](https://onlinelibrary.wiley.com/cms/asset/edbc47d4-db5d-48ea-8ea8-841fc940ee42/jimd.v44.3.cover.jpg?trick=1678057552270)
Cystathionine β‐synthase deficiency in the E‐HOD registry‐part I: pyridoxine responsiveness as a determinant of biochemical and clinical phenotype at diagnosis - Kožich - 2021 - Journal of Inherited Metabolic Disease - Wiley
![Influence of early identification and therapy on long‐term outcomes in early‐onset MTHFR deficiency - Yverneau - 2022 - Journal of Inherited Metabolic Disease - Wiley Online Library Influence of early identification and therapy on long‐term outcomes in early‐onset MTHFR deficiency - Yverneau - 2022 - Journal of Inherited Metabolic Disease - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/ec4c4dc3-f742-4032-bbb9-7daa65078615/jimd12504-toc-0001-m.jpg?trick=1679748513553)
Influence of early identification and therapy on long‐term outcomes in early‐onset MTHFR deficiency - Yverneau - 2022 - Journal of Inherited Metabolic Disease - Wiley Online Library
![PDF) Cystathionine β‐synthase deficiency in the E‐HOD registry‐Part I: pyridoxine responsiveness as a determinant of biochemical and clinical phenotype at diagnosis PDF) Cystathionine β‐synthase deficiency in the E‐HOD registry‐Part I: pyridoxine responsiveness as a determinant of biochemical and clinical phenotype at diagnosis](https://i1.rgstatic.net/publication/347835593_Cystathionine_b-synthase_deficiency_in_the_E-HOD_registry-Part_I_pyridoxine_responsiveness_as_a_determinant_of_biochemical_and_clinical_phenotype_at_diagnosis/links/5ff16e0445851553a01517fe/largepreview.png)
PDF) Cystathionine β‐synthase deficiency in the E‐HOD registry‐Part I: pyridoxine responsiveness as a determinant of biochemical and clinical phenotype at diagnosis
![Cystathionine β‐synthase deficiency in the E‐HOD registry‐part I: pyridoxine responsiveness as a determinant of biochemical and clinical phenotype at diagnosis - Kožich - 2021 - Journal of Inherited Metabolic Disease - Wiley Cystathionine β‐synthase deficiency in the E‐HOD registry‐part I: pyridoxine responsiveness as a determinant of biochemical and clinical phenotype at diagnosis - Kožich - 2021 - Journal of Inherited Metabolic Disease - Wiley](https://onlinelibrary.wiley.com/cms/asset/9a842eab-ed2a-46b5-ba6d-8482395716a6/jimd12338-fig-0002-m.jpg)